Pfizer and Allergan drug merger talks raise tax hackles in US

Pfizer and Allergan drug merger talks raise tax hackles in US

The Pfizer logo is pictured at their building in the Manhattan borough of New York October 29, 2015. REUTERS/Carlo Allegri

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter